The WHO classification of Tumours of Haematopoietic and Lymphoid Tissues of 2008 35 has recognized several EBV‐related B‐cell lymphoproliferative disorders, characterized by LMP1 and EBV nuclear antigen (EBNA) positivity, as part of latency type 3 of the virus. This evidence concerns the gene PDLIM7 and neoplasm.